FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLE (VLP)

Title:

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLE (VLP)

Document Type and Number:

Japanese Patent JP2011046715

Kind Code:

A

Abstract:

To provide high molecular protein constructs including (a) a first influenza virus M1 protein and (b) an additional structural protein, respectively.

The high molecular protein construct includes: an avian influenza virus A-type H9N2's HA protein coding sequence (GenBank registration number AJ404626); NA protein coding sequence (GenBank registration number AJ404629); M1 protein coding sequence (GenBank registration number AJ278646 protein); M2 protein coding sequence (GenBank registration number AF255363); and NP protein coding sequence (GenBank registration number AF255742). Another version of the high molecular protein construct includes: a human influenza virus A-type H3N2's HA sequence code (GenBank registration number AJ311466); and an NA sequence code (GenBank registration number AJ291403).

Inventors:

ROBINSON ROBIN A
PUSHKO PETER M

Application Number:

JP2010208644A

Publication Date:

March 10, 2011

Filing Date:

September 16, 2010

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NOVAVAX INC

International Classes:

C07K14/11; A61K39/145; A61P31/16; A61P37/04; C07H21/04; C12N7/01; C12N7/04; C12N15/09; C12P21/02; G01N33/569

Attorney, Agent or Firm:

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: SYNTHETIC METHOD AND INTERMEDIATE FOR POLYHYDROXY DIENYL LACTONE DERIVATIVE

Next Patent: METHOD FOR TREATING CANCER AND METHOD RELATED TO THE SAME